Policymakers and advocates often promote drug price transparency to lower costs and improve equity. While transparency is an important first step toward accountability and informed public budgeting, it does not guarantee affordable prices or fair access to medicines. Creating a consistent national framework could replace the current patchwork of state laws and improve oversight of how drugs are priced.
Read the full piece here.
Research for this article was supported by Arnold Ventures.
